about
Sequencing the unsequenceable: expanded CGG-repeat alleles of the fragile X geneGenetically modified pig models for neurodegenerative disorders.The external globus pallidus: progress and perspectivesPhosphorylation of mutant huntingtin at serine 116 modulates neuronal toxicity.Genetically engineered pig models for human diseases.Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72.Further investigation of phenotypes and confounding factors of progressive ratio performance and feeding behavior in the BACHD rat model of Huntington diseaseAllelic series of Huntington's disease knock-in mice reveals expression discorrelates.A family affair: brain abnormalities in siblings of patients with schizophrenia.Network analysis of human post-mortem microarrays reveals novel genes, microRNAs, and mechanistic scenarios of potential importance in fighting huntington's disease.Neuroproteomics approach and neurosystems biology analysis: ROCK inhibitors as promising therapeutic targets in neurodegeneration and neurotrauma.Protein misfolding in the late-onset neurodegenerative diseases: common themes and the unique case of amyotrophic lateral sclerosis.Fruitful research: drug target discovery for neurodegenerative diseases in Drosophila.Reassessing models of basal ganglia function and dysfunction.Exosomes and Homeostatic Synaptic Plasticity Are Linked to Each other and to Huntington's, Parkinson's, and Other Neurodegenerative Diseases by Database-Enabled Analyses of Comprehensively Curated Datasets.Modern Genome Editing Technologies in Huntington's Disease Research.Development of LC/MS/MS, high-throughput enzymatic and cellular assays for the characterization of compounds that inhibit kynurenine monooxygenase (KMO).Predicting Prognosis of Psychosis in Huntington's Disease: Case Report and Review of Literature.DNA methylation profiling in human Huntington's disease brain.Response: FACEing reality: productive tensions between our epidemiological questions, methods and mission.Elimination of huntingtin in the adult mouse leads to progressive behavioral deficits, bilateral thalamic calcification, and altered brain iron homeostasis.Reward Based Motor Adaptation Mediated by Basal Ganglia.Acute treatment with bis selenide, an organic compound containing the trace element selenium, prevents memory deficits induced by reserpine in rats.Progressive axonal transport and synaptic protein changes correlate with behavioral and neuropathological abnormalities in the heterozygous Q175 KI mouse model of Huntington's disease.A New VMAT-2 Inhibitor NBI-641449 in the Treatment of Huntington Disease.Globus pallidus degeneration and clinicopathological features of Huntington disease.Discovery of Small Molecules that Induce the Degradation of Huntingtin.Altered behavioral responses to gamma-aminobutyric acid pharmacological agents in a mouse model of Huntington's disease.Structure, function, and regulation of mitofusin-2 in health and disease.Fractionation for Resolution of Soluble and Insoluble Huntingtin Species.Striatal Mutant Huntingtin Protein Levels Decline with Age in Homozygous Huntington's Disease Knock-In Mouse Models.Studying Huntington's Disease in Yeast: From Mechanisms to Pharmacological Approaches
P2860
Q24596776-F04125CB-15F1-4D56-BE44-EFFE24D04AB2Q31002975-8200AD51-519E-4217-8D69-0D74C732ADDEQ34512150-EE0149A2-C413-495B-8A5D-582E93770874Q35088655-0B3F9CA6-397B-465D-9323-51C61E2BF807Q35700104-4908F0DD-37E6-4105-A766-324AC820DC59Q35776923-5704E6B4-0899-47B6-90DB-EA9A25C4E08FQ36300780-B345CEA6-B7B7-4EB2-A8F3-E6D8799A1A8BQ36722685-DCE80A51-EC62-403C-AB87-06B228EC5AAFQ37256194-52B2C018-9A16-455E-BA72-43129CBAFE04Q37453183-EF8F1702-B159-42AF-92CA-B004A3A2E38FQ38060658-9D987611-2D95-4A96-9D25-002CB419CA14Q38091029-CF7DD73B-2D40-49D7-9CBA-F60C105771D3Q38154940-63ED4A4E-BE84-4190-B492-740FC03EA1E7Q38230498-2D4142DC-D390-4B14-9B77-6258CFE99B69Q38726920-9265F3BF-AA61-4D96-8314-82A9D62010C7Q39106522-EC5B2A76-CA6D-4B8A-BDEB-F88D46808534Q39149450-C36CE6A1-EEAC-4252-8A0F-3F52002E5B59Q39426900-9B3B6476-6A9C-4B67-9485-180D1D2E1970Q39940087-4F44F945-F745-4110-859D-BFD286C7CEECQ40361332-2345546D-E505-4C98-A18D-C36E6223A18DQ41187089-FCEB3437-F7D6-42E3-9B02-F96C0C7E9203Q41888073-9E03B72F-81C4-43D8-A55C-FE2E8EC405E9Q42675514-A8434DBA-1FB0-4A35-92D1-CA10908C5AEAQ44186888-778D4B19-A36E-4879-B51C-B4D681091F48Q45288855-2F69C961-B76A-4D8B-94DC-18974C3DAF15Q45295460-BEBD2160-12A0-4EEC-9C49-D12872FA6E01Q45303178-DC20971C-EC6B-477F-8B96-10236F86FE7AQ45303467-09CFAC2F-3982-423A-87FA-E9E0E4AB02B3Q47606530-176AA295-532A-48E1-95FD-94A151B5D660Q52350721-64B0A70E-92F6-45EA-A185-5FE117FA4669Q55284103-EEE979BB-D4FA-4BD9-89B2-391C9FBBBFB0Q58764761-27B18BAF-1FD0-44E9-848B-F64DFA1852FB
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Genetics and neuropathology of Huntington's disease
@ast
Genetics and neuropathology of Huntington's disease
@en
Genetics and neuropathology of Huntington's disease
@nl
type
label
Genetics and neuropathology of Huntington's disease
@ast
Genetics and neuropathology of Huntington's disease
@en
Genetics and neuropathology of Huntington's disease
@nl
prefLabel
Genetics and neuropathology of Huntington's disease
@ast
Genetics and neuropathology of Huntington's disease
@en
Genetics and neuropathology of Huntington's disease
@nl
P2093
P2860
P1476
Genetics and neuropathology of Huntington's disease
@en
P2093
Anton Reiner
Ioannis Dragatsis
Paula Dietrich
P2860
P304
P356
10.1016/B978-0-12-381328-2.00014-6
P407
P577
2011-01-01T00:00:00Z